Abstract | PURPOSE: METHODS: The ATBC trial conducted from 1985 to 1993 enrolled 29,133 male smokers. We used Cox proportional hazards regression models to estimate hazard ratios (HRs) and confidence intervals (CIs), using men who drank more than 0 but less than 1 cup coffee/d and tea nondrinkers as our referent group for coffee and tea analyses, respectively. RESULTS: During 472,402 person-years of follow-up, 835 incident cases of bladder cancer and 366 cases of renal cell carcinoma were ascertained. For bladder cancer, we observed no association for coffee consumption (HR ≥4 vs. >0 to <1 cups/d = 1.16, 95% CI = 0.86-1.56) and a borderline statistically significant inverse association for tea consumption (HR ≥1 vs. 0 cup/d = 0.77, 95% CI = 0.58-1.00). For renal cell carcinoma, we observed no association for coffee (HR ≥4 vs. >0 to <1 cups/d = 0.85, 95% CI = 0.55-1.32) or tea consumption (HR ≥1 vs. 0 cup/d = 1.00, 95% CI = 0.68-1.46). We found no impact of coffee preparation on coffee- cancer associations. CONCLUSIONS:
|
Authors | Maryam Hashemian, Rashmi Sinha, Gwen Murphy, Stephanie J Weinstein, Linda M Liao, Neal D Freedman, Christian C Abnet, Demetrius Albanes, Erikka Loftfield |
Journal | Annals of epidemiology
(Ann Epidemiol)
Vol. 34
Pg. 33-39
(06 2019)
ISSN: 1873-2585 [Electronic] United States |
PMID | 31023511
(Publication Type: Journal Article, Research Support, N.I.H., Intramural)
|
Copyright | Published by Elsevier Inc. |
Chemical References |
- Coffee
- Tea
- beta Carotene
- alpha-Tocopherol
|
Topics |
- Adult
- Aged
- Carcinoma, Renal Cell
(epidemiology, etiology)
- Coffee
(adverse effects)
- Cohort Studies
- Female
- Finland
(epidemiology)
- Humans
- Incidence
- Male
- Middle Aged
- Prospective Studies
- Risk Assessment
- Tea
(adverse effects)
- Urinary Bladder Neoplasms
(epidemiology, etiology)
- Urologic Neoplasms
(epidemiology, etiology)
- alpha-Tocopherol
- beta Carotene
|